Innospec vs Ingevity
IOSP and NGVT side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IOSP and NGVT compare
Innospec and Ingevity are about the same size, with market caps of $2.0B and $2.1B.
Innospec grew revenue faster over the last twelve months (4.7% versus −3.7% for Ingevity).
Innospec pays a dividend yielding 2.2%; Ingevity does not pay one.
Innospec scores higher on the StockData Score (14 against 6 for Ingevity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IOSP | NGVT |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $2.1B |
| Share price | $80.39 | $61.72 |
| Change, 1 year | 7.4% | 25.6% |
| Change, 5 years | −7.9% | −21.7% |
| Beta (5Y) | 0.86 | 1.21 |
| Employees | 2,450 | 1,500 |
| StockData Score | ||
| Total score | 14 (better) | 6 |
| Valuation score | 4 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 6 (better) | 1 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | – | 36.3× |
| P/S | 1.1× (better) | 1.9× |
| P/B | 1.4× (better) | 33.7× |
| EV/EBITDA | 8.5× (better) | 23.1× |
| P/FCF | – | 17.3× |
| FCF yield | – | 5.8% |
| Fair value | $109.30 | $35.71 |
| Margin of safety | 26.5% (better) | −72.8% |
| Growth | ||
| Revenue growth (TTM) | 4.7% (better) | −3.7% |
| Revenue growth, 5Y average | 8.3% (better) | −0.81% |
| EPS growth, 5Y average | 32.1% | – |
| Profitability | ||
| Gross margin | 27.7% | 42.0% (better) |
| Operating margin | 8.8% | – |
| Net margin | – | 5.3% |
| FCF margin | – | 10.8% |
| Return on equity | – | 59.5% |
| Return on invested capital | 12.4% | – |
| Financial health | ||
| Debt / equity | 0.00 | 18.18 (better) |
| Net debt / EBITDA | – | 7.68 |
| Current ratio | 2.95 (better) | 1.48 |
| Altman Z-score | 5.12 (better) | 2.29 |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | – |
| Years of dividend growth | 12 | – |
| Dividend growth, 5Y average | 10.5% | – |
| Buyback yield | 0.68% | 7.4% (better) |
| Shareholder yield | 2.9% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 101% | 102% |
| Held by insiders | 1.6% | 1.4% |
| Insider net buying, 12 months | −$874K (better) | −$1.8M |
| Short interest, % of float | 1.9% | 3.7% |
Go deeper
- IOSP stock overview
- IOSP income statement
- IOSP valuation and score
- NGVT stock overview
- NGVT income statement
- NGVT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.